BMY in the 13F filings

Bristol-myers Squibb Co · CUSIP 110122108

Sector · Pharmaceuticals and biotechnology Theme · Healthcare: biopharma and medtech· L3VLUP-defined Theme · Pharmaceutical preparations

Quarter

Q3 2026 · early filers Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023

Quarter end: 30 Jun 2026; the date the book describes
Filed: 27 Oct 2026; latest of these filings; the earliest 3 Aug 2026
Managers listing it: 34; at least, of 95 tracked, among listed positions
Comparable managers: 91; filed both Q1 2026 and Q2 2026; 24 listed it in both
Shares listed: 145,527,740; combined, among listed positions
Reported value: $8.4bn; combined, at the quarter end

1 line marked †. Value as filed implies a price far from other filers'. Each counts in holders and value as filed, and is left out of the net change in shares.

AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.

Among the 91 comparable managers: 15 buyers (opened or added shares) and 23 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +2,884,694.

Managers listing BMY in Q2 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2026, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

ActionShare of book at least

34 of 34 holders

				Action		Filing
T. Rowe Price Associates Inc	31,707,643	$1.8bn	0.18%	Added	+21,457,405	14 Aug 2026 (the filing on sec.gov)
AQR Capital Management LLC	27,357,486	$1.6bn	0.55%	Trimmed	-2,273,619	14 Aug 2026 (the filing on sec.gov)
Fidelity (FMR LLC)	16,293,303	$939m	under 0.1%	Added	+5,622,200	13 Aug 2026 (the filing on sec.gov)
Invesco Ltd	16,033,480	$924m	0.07%	Added	+523,481	14 Aug 2026 (the filing on sec.gov)
Acadian Asset Management LLC	11,593,352	$668m	0.79%	Trimmed	-294,316	13 Aug 2026 (the filing on sec.gov)
Two Sigma Investments LP	10,085,383	$581m	0.42%	Trimmed	-1,449,723	14 Aug 2026 (the filing on sec.gov)
Arrowstreet Capital LP	8,585,846	$495m	0.22%	Trimmed	-286,933	13 Aug 2026 (the filing on sec.gov)
AllianceBernstein LP	4,757,720	$289m	0.10%	Trimmed	-114,960	14 Aug 2026 (the filing on sec.gov)
Man Group PLC	4,682,000	$270m	0.43%	Trimmed	-976,497	14 Aug 2026 (the filing on sec.gov)
Wellington Management Group LLP	3,914,086	$226m	under 0.1%	Trimmed	-1,592,910	14 Aug 2026 (the filing on sec.gov)
Capital World Investors	2,244,242	$129m	under 0.1%	Added	+19,212	12 Aug 2026 (the filing on sec.gov)
Citadel Advisors LLC	1,572,329	$91m	under 0.1%	Added	+78,095	2 Sep 2026 (the filing on sec.gov)
Woodline Partners LP	1,167,476	$67m	0.21%	Added	+46,838	14 Aug 2026 (the filing on sec.gov)
Neuberger Berman Group LLC	972,843	$56m	under 0.1%	Added	+88,540	27 Oct 2026 (the filing on sec.gov)
MFS Investment Management	948,427	$55m	under 0.1%	Trimmed	-102,388	3 Aug 2026 (the filing on sec.gov)
Millennium Management LLC	752,576	$43m	under 0.1%	Trimmed	-5,792,866	14 Aug 2026 (the filing on sec.gov)
Janus Henderson Group Ltd	704,213	$41m	under 0.1%	Trimmed	-208,713	14 Aug 2026 (the filing on sec.gov)
D. E. Shaw & Co.	559,407	$32m	under 0.1%	Added	+249,569	14 Aug 2026 (the filing on sec.gov)
Squarepoint Ops LLC	324,626	$19m	under 0.1%	Added	+270,492	14 Aug 2026 (the filing on sec.gov)
ExodusPoint Capital Management LP	253,748	$15m	0.09%	Added	+143,563	14 Aug 2026 (the filing on sec.gov)
Susquehanna International Group LLP	185,612	$11m	under 0.1%	Trimmed	-415,277	14 Aug 2026 (the filing on sec.gov)
Brevan Howard Capital Management LP	163,962	$9.4m	0.07%	Trimmed	-6,549	14 Aug 2026 (the filing on sec.gov)
Voloridge Investment Management LLC	145,551	$8.4m	under 0.1%	New	new	14 Aug 2026 (the filing on sec.gov)
Balyasny Asset Management LLC	88,288	$5.1m	under 0.1%	Trimmed	-30,409	14 Aug 2026 (the filing on sec.gov)
Jane Street Group LLC	86,291	$5.0m	under 0.1%	Trimmed	-2,179,217	14 Aug 2026 (the filing on sec.gov)

Page 1 of 2

What managers have written about BMY

Shown because the letter names the company. A letter is commentary; it is not a record of why a position changed.

Starboard's February 2019 letter to Bristol-Myers Squibb shareholders on the Celgene deal28 Feb 2019 · Activist letter · Subject of the letter · Starboard Value LP’s 13F
Before the letter
31 Dec 2018 (Q4 2018 13F): not among Starboard Value LP’s listed positions. A holding below the listed range, under another security, or none at all would read the same.
After the letter
31 Mar 2019 (Q1 2019 13F): not among Starboard Value LP’s listed positions. A holding below the listed range, under another security, or none at all would read the same.

Every letter beside its positions →

Largest increases and reductions, by shares

Q1 2026 to Q2 2026, among managers that listed it in both quarters or opened it.

Increases

T. Rowe Price Associates Incexisting position · 31,707,643 shares now+21,457,405
Fidelity (FMR LLC)existing position · 16,293,303 shares now+5,622,200
Invesco Ltdexisting position · 16,033,480 shares now+523,481
Squarepoint Ops LLCexisting position · 324,626 shares now+270,492
D. E. Shaw & Co.existing position · 559,407 shares now+249,569

Reductions

Millennium Management LLCexisting position · 752,576 shares now-5,792,866
Dodge & Coxexisting position · 42,361 shares now-4,580,459
Marshall Wace LLPexisting position · 15,169 shares now-3,674,669
AQR Capital Management LLCexisting position · 27,357,486 shares now-2,273,619
Jane Street Group LLCexisting position · 86,291 shares now-2,179,217

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (3)

Voloridge Investment Management LLC$8.4m
Hudson Bay Capital Management LP$3.3m
Verition Fund Management LLC$374k

Exited (4)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.

31 in Q3 2024 to 22 in Q2 2026

Tracked managers listing it, at least.

the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.

BMY by quarter
Quarter	Holders	Reported value	Buyers	Sellers
Q2 2013	22	$12.2bn	n.a.	n.a.
Q3 2013	24	$13.4bn	n.a.	n.a.
Q4 2013	23	$14.8bn	n.a.	n.a.
Q1 2014	26	$14.9bn	n.a.	n.a.
Q2 2014	25	$14.7bn	n.a.	n.a.
Q3 2014	24	$15.8bn	n.a.	n.a.
Q4 2014	21	$18.3bn	n.a.	n.a.
Q1 2015	29	$20.3bn	n.a.	n.a.
Q2 2015	24	$21.7bn	n.a.	n.a.
Q3 2015	29	$19.9bn	n.a.	n.a.
Q4 2015	29	$22.5bn	n.a.	n.a.
Q1 2016	27	$21.3bn	n.a.	n.a.
Q2 2016	31	$24.0bn	n.a.	n.a.
Q3 2016	33	$16.9bn	n.a.	n.a.
Q4 2016	33	$20.1bn	n.a.	n.a.
Q1 2017	36	$17.9bn	n.a.	n.a.
Q2 2017	36	$17.8bn	n.a.	n.a.
Q3 2017	34	$20.2bn	n.a.	n.a.
Q4 2017	35	$19.0bn	n.a.	n.a.
Q1 2018	32	$19.3bn	n.a.	n.a.
Q2 2018	33	$18.0bn	n.a.	n.a.
Q3 2018	35	$19.9bn	n.a.	n.a.
Q4 2018	36	$16.6bn	n.a.	n.a.
Q1 2019	44	$16.9bn	n.a.	n.a.
Q2 2019	31	$16.8bn	n.a.	n.a.
Q3 2019	31	$18.0bn	n.a.	n.a.
Q4 2019	29	$24.1bn	n.a.	n.a.
Q1 2020	29	$18.9bn	n.a.	n.a.
Q2 2020	35	$18.0bn	n.a.	n.a.
Q3 2020	31	$18.8bn	n.a.	n.a.
Q4 2020	28	$16.4bn	n.a.	n.a.
Q1 2021	31	$15.2bn	n.a.	n.a.
Q2 2021	27	$16.3bn	n.a.	n.a.
Q3 2021	30	$14.2bn	n.a.	n.a.
Q4 2021	28	$12.9bn	n.a.	n.a.
Q1 2022	28	$15.2bn	n.a.	n.a.
Q2 2022	31	$14.8bn	n.a.	n.a.
Q3 2022	27	$12.2bn	n.a.	n.a.
Q4 2022	33	$10.0bn	n.a.	n.a.
Q1 2023	29	$8.4bn	n.a.	n.a.
Q2 2023	29	$7.9bn	n.a.	n.a.
Q3 2023	32	$7.5bn	n.a.	n.a.
Q4 2023	30	$7.2bn	19	12
Q1 2024	20	$6.6bn	12	10
Q2 2024	26	$6.4bn	17	10
Q3 2024	31	$7.9bn	18	13
Q4 2024	27	$6.6bn	14	13
Q1 2025	20	$6.6bn	9	13
Q2 2025	22	$5.6bn	16	8
Q3 2025	28	$5.4bn	19	9
Q4 2025	25	$7.7bn	13	27
Q1 2026	27	$8.3bn	17	22
Q2 2026	22	$8.2bn	15	23

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

BMY and LLY →BMY and JNJ →BMY and VRTX →Choose a stock to compare with BMY →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own BMY, latest filings →Back to the 13F Explorer →

Provided for information purposes only, not financial advice. The holdings shown here and anything drawn from them are illustrative, produced from assumptions you control, and must not be relied on for any investment, financial or business decision. Read the full notice

Not advice, and not a recommendation. Everything L3VLUP publishes is provided for information purposes only. Nothing here is financial, investment, legal, tax or accounting advice, a personal recommendation, or an offer or solicitation to buy or sell any security or financial instrument. It takes no account of anyone’s objectives, financial situation or needs.

Not a regulated adviser. L3VLUP does not provide regulated financial services. Speak to a suitably qualified and regulated professional before acting on anything you read here.

Illustrative figures. Default values are plausible starting points chosen so a model has somewhere to begin. They are not data, not a view on any company, and not calibrated to anything. Outputs move with whatever you type in.

Third-party data. Where live figures appear they come from third parties, including public filings and market feeds. They may be delayed, incomplete, restated, mis-tagged at source or simply wrong, and their providers do not endorse or verify this page. Every figure links to where it came from. Check it there before relying on it. Past performance is not a guide to future performance.

Company names and logos. Names, tickers and logos are the trademarks of their owners and appear only to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, none of them took part in preparing the exercise, and nothing here is a statement by or about any of them. See third-party names and marks.

No warranty, and limited liability. This page is provided “as is” without warranty of any kind. To the fullest extent permitted by law, L3VLUP accepts no liability for any loss or damage arising from use of, or reliance on, anything on it. Nothing in this notice limits any liability that cannot lawfully be limited.

Full terms: Information Purposes and No Advice · Terms